Canada markets open in 5 hours 56 minutes

Finch Therapeutics Group, Inc. (FNCH)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
2.1800-0.0600 (-2.68%)
At close: 04:00PM EDT
2.2400 +0.06 (+2.75%)
After hours: 04:25PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
107
107
861
18,532
7,719
Cost of Revenue
-
-
-
-
0
Gross Profit
-
-
-
-
7,719
Operating Expenses
Research Development
7,199
7,199
52,863
57,279
33,144
Selling General and Administrative
26,910
26,910
36,192
21,238
14,011
Total Operating Expenses
34,109
34,109
89,055
78,517
47,155
Operating Income or Loss
-34,002
-34,002
-88,194
-59,985
-39,436
Total Other Income/Expenses Net
-45,783
-45,783
-26,704
1,803
-11
Income Before Tax
-78,215
-78,215
-114,646
-58,160
-39,341
Income Tax Expense
-3,461
-3,461
0
0
0
Income from Continuing Operations
-74,754
-74,754
-114,646
-58,160
-39,341
Net Income
-74,754
-74,754
-114,646
-58,160
-39,341
Net Income available to common shareholders
-74,754
-74,754
-114,646
-58,160
-39,341
Basic EPS
-61.48
-
-72.12
-44.40
-25.72
Diluted EPS
-61.48
-
-72.12
-44.40
-25.72
Basic Average Shares
1,603
-
1,590
1,307
1,530
Diluted Average Shares
1,603
-
1,590
1,307
1,530